ITMI20031127A1 - Anticorpi anti-hgf-r e loro uso - Google Patents
Anticorpi anti-hgf-r e loro usoInfo
- Publication number
- ITMI20031127A1 ITMI20031127A1 IT001127A ITMI20031127A ITMI20031127A1 IT MI20031127 A1 ITMI20031127 A1 IT MI20031127A1 IT 001127 A IT001127 A IT 001127A IT MI20031127 A ITMI20031127 A IT MI20031127A IT MI20031127 A1 ITMI20031127 A1 IT MI20031127A1
- Authority
- IT
- Italy
- Prior art keywords
- antibodies
- hgf
- relates
- hfg
- secretes
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2863—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against receptors for growth factors, growth regulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
- C07K2317/75—Agonist effect on antigen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
- C07K2317/76—Antagonist effect on antigen, e.g. neutralization or inhibition of binding
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/81—Packaged device or kit
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/808—Materials and products related to genetic engineering or hybrid or fused cell technology, e.g. hybridoma, monoclonal products
- Y10S530/809—Fused cells, e.g. hybridoma
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Priority Applications (8)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT001127A ITMI20031127A1 (it) | 2003-06-05 | 2003-06-05 | Anticorpi anti-hgf-r e loro uso |
AT04741691T ATE466031T1 (de) | 2003-06-05 | 2004-06-01 | Anti-hgf-r-antikörper und deren verwendung |
DK04741691.2T DK1641828T3 (da) | 2003-06-05 | 2004-06-01 | Anti-HGF-R-antistoffer og deres anvendelse |
US10/559,305 US7556804B2 (en) | 2003-06-05 | 2004-06-01 | Anti-HGF-R antibodies and their use |
CA002524329A CA2524329A1 (en) | 2003-06-05 | 2004-06-01 | Anti-hgf-r antibodies and their use |
EP04741691A EP1641828B1 (en) | 2003-06-05 | 2004-06-01 | Anti-hgf-r antibodies and their use |
DE602004026872T DE602004026872D1 (de) | 2003-06-05 | 2004-06-01 | Anti-hgf-r-antikörper und deren verwendung |
PCT/EP2004/050976 WO2004108766A2 (en) | 2003-06-05 | 2004-06-01 | Anti-hgf-r antibodies and their use |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT001127A ITMI20031127A1 (it) | 2003-06-05 | 2003-06-05 | Anticorpi anti-hgf-r e loro uso |
Publications (2)
Publication Number | Publication Date |
---|---|
ITMI20031127A0 ITMI20031127A0 (it) | 2003-06-05 |
ITMI20031127A1 true ITMI20031127A1 (it) | 2004-12-06 |
Family
ID=30131145
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IT001127A ITMI20031127A1 (it) | 2003-06-05 | 2003-06-05 | Anticorpi anti-hgf-r e loro uso |
Country Status (8)
Country | Link |
---|---|
US (1) | US7556804B2 (it) |
EP (1) | EP1641828B1 (it) |
AT (1) | ATE466031T1 (it) |
CA (1) | CA2524329A1 (it) |
DE (1) | DE602004026872D1 (it) |
DK (1) | DK1641828T3 (it) |
IT (1) | ITMI20031127A1 (it) |
WO (1) | WO2004108766A2 (it) |
Families Citing this family (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PA8849001A1 (es) * | 2008-11-21 | 2010-06-28 | Lilly Co Eli | Anticuerpos de c-met |
MX2011010166A (es) | 2009-04-07 | 2011-10-11 | Roche Glycart Ag | Anticuerpos biespecificos anti-erbb-3/anti-c-met. |
SG175078A1 (en) | 2009-04-07 | 2011-11-28 | Roche Glycart Ag | Bispecific anti-erbb-1/anti-c-met antibodies |
KR101671378B1 (ko) * | 2009-10-30 | 2016-11-01 | 삼성전자 주식회사 | c-Met에 특이적으로 결합하는 항체 및 그의 용도 |
KR101748707B1 (ko) * | 2009-11-27 | 2017-06-20 | 삼성전자주식회사 | c-Met에 특이적으로 결합하는 항체 및 그를 이용한 암 진단용 키트 |
ITTO20091020A1 (it) * | 2009-12-21 | 2011-06-22 | Uni Degli Studi Del Piemonte Orientale Ame | "cardiomyocytes anti-apoptotic molecules, products and compositions thereof" |
NZ602294A (en) | 2010-03-10 | 2015-04-24 | Genmab As | Monoclonal antibodies against c-met |
RU2608644C2 (ru) | 2010-11-03 | 2017-01-23 | арДЖЕН-ИКС Н.В. | Антитела против белка рецептора с-мет |
MX2014002289A (es) | 2011-08-26 | 2015-03-20 | Merrimack Pharmaceuticals Inc | Anticuerpos fc especificos en tandem. |
CA2843771A1 (en) | 2011-09-20 | 2013-03-28 | Eli Lilly And Company | Anti-c-met antibodies |
EP2773660A2 (en) | 2011-11-03 | 2014-09-10 | Argen-X B.V. | Chimeric human-camel antigens and their use |
US8900582B2 (en) | 2011-12-22 | 2014-12-02 | Samsung Electronics Co., Ltd. | Deimmunized anti c-Met humanized antibodies and uses thereof |
EP2727941A1 (en) | 2012-11-05 | 2014-05-07 | MAB Discovery GmbH | Method for the production of multispecific antibodies |
WO2014067642A1 (en) | 2012-11-05 | 2014-05-08 | Mab Discovery Gmbh | Method for the production of multispecific antibodies |
WO2014138449A1 (en) | 2013-03-06 | 2014-09-12 | Merrimack Pharmaceuticals, Inc. | Anti-c-met tandem fc bispecific antibodies |
US9168300B2 (en) | 2013-03-14 | 2015-10-27 | Oncomed Pharmaceuticals, Inc. | MET-binding agents and uses thereof |
KR20160137599A (ko) | 2014-03-24 | 2016-11-30 | 제넨테크, 인크. | C-met 길항제로의 암 치료 및 이것과 hgf 발현과의 상관관계 |
WO2016042412A1 (en) | 2014-09-16 | 2016-03-24 | Symphogen A/S | Anti-met antibodies and compositions |
WO2016149265A1 (en) | 2015-03-16 | 2016-09-22 | Kolltan Pharmaceuticals, Inc. | Anti-met antibodies and methods of use thereof |
GB201611123D0 (en) | 2016-06-27 | 2016-08-10 | Euremab Srl | Anti met antibodiesand uses thereof |
TWI782930B (zh) | 2016-11-16 | 2022-11-11 | 美商再生元醫藥公司 | 抗met抗體,結合met之雙特異性抗原結合分子及其使用方法 |
IT201800000535A1 (it) | 2018-01-03 | 2019-07-03 | Procedimenti per la cura del cancro. | |
KR102396194B1 (ko) * | 2018-12-07 | 2022-05-10 | 서울대학교 산학협력단 | 항 c-Met 아고니스트 항체 및 이의 용도 |
KR102433184B1 (ko) * | 2018-12-07 | 2022-08-17 | 서울대학교 산학협력단 | 항 c-Met 아고니스트 항체 및 이의 용도 |
JP2022547274A (ja) | 2019-09-16 | 2022-11-11 | リジェネロン・ファーマシューティカルズ・インコーポレイテッド | 免疫pet撮像のための放射標識されたmet結合タンパク質 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
HUT67009A (en) | 1991-05-10 | 1995-01-30 | Erba Carlo Spa | Truncated forms of the hepatocyte growth factor (hgf) receptor pharmaceutical compositions containing them and process for production of them |
US5686292A (en) * | 1995-06-02 | 1997-11-11 | Genentech, Inc. | Hepatocyte growth factor receptor antagonist antibodies and uses thereof |
US6214344B1 (en) * | 1995-06-02 | 2001-04-10 | Genetech, Inc. | Hepatocyte growth factor receptor antagonists and uses thereof |
DK0922102T3 (da) * | 1996-07-03 | 2010-08-16 | Genentech Inc | Receptor-agonister af hepatocyt-vækstfaktor og anvendelser deraf |
-
2003
- 2003-06-05 IT IT001127A patent/ITMI20031127A1/it unknown
-
2004
- 2004-06-01 CA CA002524329A patent/CA2524329A1/en not_active Abandoned
- 2004-06-01 AT AT04741691T patent/ATE466031T1/de active
- 2004-06-01 DK DK04741691.2T patent/DK1641828T3/da active
- 2004-06-01 US US10/559,305 patent/US7556804B2/en not_active Expired - Fee Related
- 2004-06-01 WO PCT/EP2004/050976 patent/WO2004108766A2/en active Search and Examination
- 2004-06-01 EP EP04741691A patent/EP1641828B1/en not_active Expired - Lifetime
- 2004-06-01 DE DE602004026872T patent/DE602004026872D1/de not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
US7556804B2 (en) | 2009-07-07 |
WO2004108766A2 (en) | 2004-12-16 |
US20060140940A1 (en) | 2006-06-29 |
DE602004026872D1 (de) | 2010-06-10 |
EP1641828B1 (en) | 2010-04-28 |
DK1641828T3 (da) | 2010-08-02 |
WO2004108766A3 (en) | 2005-06-30 |
ATE466031T1 (de) | 2010-05-15 |
EP1641828A2 (en) | 2006-04-05 |
ITMI20031127A0 (it) | 2003-06-05 |
CA2524329A1 (en) | 2004-12-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ITMI20031127A1 (it) | Anticorpi anti-hgf-r e loro uso | |
RS53984B1 (en) | IP-10 ANTIBODIES AND THEIR USES | |
CY1112277T1 (el) | ΑΝΘΡΩΠΟΠΟΙΗΜΕΝΟΙ ΑΝΤΑΓΩΝΙΣΤΕΣ ΑΝΤΙ-β7 ΚΑΙ ΧΡΗΣΕΙΣ ΑΥΤΩΝ | |
NO20071436L (no) | Humaniserte Anti-5T4 antistoffer og Anti-5T4 antistoff/calicheamicin konjugater | |
DK1773885T3 (da) | Humaniserede anti-c-met-antagonister | |
CY2012019I1 (el) | Ανθρωπινα μονοκλωνα αντισωματα εναντια στο cd20 | |
EA200401198A1 (ru) | АНТИТЕЛА ПРОТИВ αvβ6 | |
EA200700083A1 (ru) | Антитела, направленные против бета-амилоидного пептида, и способы их применения | |
AR057807A1 (es) | Formulaciones de anticuerpo anti-cd3 | |
NZ594466A (en) | Human monoclonal antibodies to protein tyrosine kinase 7 (PTK7) and methods for using anti-PTK7 antibodies | |
CY1110759T1 (el) | Παραλλαγες ανοσοσφαιρινων και χρησεις αυτων | |
ATE502052T1 (de) | Monoklonale antikörper gegen den humanen anti- müllerian-hormonrezeptor vom typ ii (amhr-ii) | |
AR052284A1 (es) | Variantes de un anticuerpo y usos de las mismas | |
ATE553778T1 (de) | Für humanes hepcidin spezifische antikörper | |
CL2007003825A1 (es) | Composicion farmaceutica que comprende un anticuerpo monoclonal humanizado anti-antigeno de diferenciacion leucocitario humano cd6; y su uso para el diagnostico y tratamiento de la leucemia linfocitaria cronica b. | |
UA94211C2 (ru) | Выделенное полностью человеческое моноклональное cd3 антитело | |
FI20020807A0 (fi) | Uusia humanisoituja anti-VAP-1 monoklonaalisia vasta-aineita | |
ATE506966T1 (de) | Humanisierte super-antikörper |